ACTIVATION OF PROUROKINASE BY CATHEPSIN-G IN THE PRESENCE OF GLUCOSAMINOGLYCANS

被引:7
作者
DRAG, B [1 ]
PETERSEN, LC [1 ]
机构
[1] NOVO NORDISK AS,BIOPHARMACEUT DIV RES,DK-2820 GENTOFTE,DENMARK
关键词
D O I
10.1016/S0268-9499(05)80019-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of extracellular matrix glycosaminoglycans (GAGs) on the activity of cathepsin G (Cat G) was investigated. Heparin inhibited the amidolytic activity of Cat G with some peptidyl substrates, whereas it enhanced the activity with others. The effect on Cat G activity was observed with high M(r) heparin as well as with fractions of relatively low M(r). This is in contrast to the effect of heparin on the activity of human leukocyte elastase (HLE) where the effect was observed only with high M(r) fractions. The Cat G-mediated activation of pro-u-PA was also investigated. In agreement with previous observations (Learmonth et al. Fibrinolysis 1992; 6 (suppl 4): 113-116) we found that Cat G cleaved pro-u-PA primarily in the epidermal growth factor-like domain, and secondarily at, or close to the activation site. Our results showed that the interaction between Cat G and pro-u-PA was strongly enhanced by heparin, and that 75% conversion into an active u-PA form could be obtained. Stimulation of Cat G-catalyzed activation of pro-u-PA was also observed with heparan sulphate and chondroitin sulphate A, B and C. The effect of various fractions of heparin was investigated and shown to depend strongly on the M(r) with little or no stimulation of the low-M(r) fractions. We propose that a substantial amount of active u-PA with impaired receptor binding may accumulate under some conditions as a result of influx and activation of neutrophils.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 43 条
  • [1] APPELLA E, 1987, J BIOL CHEM, V262, P4437
  • [2] GRAPHICAL AND STATISTICAL-ANALYSIS OF HYPERBOLIC TIGHT-BINDING INHIBITION
    BAICI, A
    [J]. BIOCHEMICAL JOURNAL, 1987, 244 (03) : 793 - 796
  • [3] HUMAN LEUKOCYTE GRANULE ELASTASE - RAPID ISOLATION AND CHARACTERIZATION
    BAUGH, RJ
    TRAVIS, J
    [J]. BIOCHEMISTRY, 1976, 15 (04) : 836 - 841
  • [4] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS
    BLASI, F
    VASSALLI, JD
    DANO, K
    [J]. JOURNAL OF CELL BIOLOGY, 1987, 104 (04) : 801 - 804
  • [5] IDENTIFICATION OF A HIGHLY MOBILIZABLE SUBSET OF HUMAN NEUTROPHIL INTRACELLULAR VESICLES THAT CONTAINS TETRANECTIN AND LATENT ALKALINE-PHOSPHATASE
    BORREGAARD, N
    CHRISTENSEN, L
    BJERRUM, OW
    BIRGENS, HS
    CLEMMENSEN, I
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) : 408 - 416
  • [6] CUBELLIS MV, 1986, J BIOL CHEM, V261, P5819
  • [7] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [8] ELLIS V, 1989, J BIOL CHEM, V264, P2185
  • [9] EVANGELISTA V, 1991, BLOOD, V77, P2379
  • [10] EFFECTIVE ACTIVATION OF THE PROENZYME FORM OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PRO-UPA) BY THE CYSTEINE PROTEASE CATHEPSIN-L
    GORETZKI, L
    SCHMITT, M
    MANN, K
    CALVETE, J
    CHUCHOLOWSKI, N
    KRAMER, M
    GUNZLER, WA
    JANICKE, F
    GRAEFF, H
    [J]. FEBS LETTERS, 1992, 297 (1-2) : 112 - 118